We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

New Jersey

  • February 22, 2008

    Prodisc Patient Widens Circle Of Blame

    A patient whose artificial spinal disk malfunctioned is broadening his product liability lawsuit against Synthes Spine Inc., which manufactures and markets the disk, adding as defendants the device's original maker and the investment firm that generated the start-up capital to finance the product's development.

  • February 21, 2008

    Smith & Nephew, Synthes Patent Case Settled

    A federal judge has approved a deal that resolves a patent suit Smith & Nephew Plc filed against Synthes Inc. in 2002 and dissolves a 2006 injunction.

  • February 21, 2008

    Louisiana Accuses Amgen Of Tying Cancer Drugs

    The state of Louisiana and its health department have accused biotech company Amgen Inc. of using its monopoly in the market for one type of anti-cancer drug to boost the sales of a second anti-cancer drug through tying, in violation of state antitrust laws.

  • February 21, 2008

    Diamond Wholesaler Objects To Fortunoff Sale

    Diamond wholesaler Verstandig & Sons Inc. filed a limited objection on Wednesday to the sale of bankrupt Fortunoff Fine Jewelry and Silverware LLC, alleging that Fortunoff is still in possession of Verstandig property that it intends to sell along with other assets as part of the general sale proposal.

  • February 22, 2008

    Alpharma Loses Bid To Get State Wage Claims Tossed

    A judge has denied a motion by Alpharma Inc. to dismiss part of a proposed class action that alleges the company violated the Fair Labor Standards Act and the New Jersey Wage Collection Law by not paying wages and overtime to sales representatives and regional account specialists.

  • February 20, 2008

    Sandata Loses Bid To Toss Infocrossing Counterclaims

    A district court judge has denied Sandata Technologies' attempt to terminate the antitrust allegations that Infocrossing Inc. asserted in response to Sandata's lawsuit over patents for health care worker monitoring systems.

  • February 20, 2008

    Third Refco Executive Pleads Guilty To Fraud

    Just days after former Refco CEO Philip Bennett pled guilty to playing a role in the fraud that felled the once high-flying brokerage, another former executive has followed suit.

  • February 20, 2008

    Judge Approves Congoleum's Disclosure Statement

    A bankruptcy judge has approved Congoleum Corp.'s disclosure statement, setting the stage for possible approval of the flooring company's reorganization plan later this year.

  • February 19, 2008

    Ex-Refco CEO Faces Civil Suit From SEC

    Former Refco Inc. Chief Executive Phillip R. Bennett, who is already facing the possible equivalent of a life sentence after pleading guilty to 20 criminal counts on Friday, was sued by the U.S. Securities and Exchange Commission on Tuesday for concealing Refco's finances from investors.

  • February 19, 2008

    High Court Declines Appeal In Ear-Drop Patent Case

    The United States Supreme Court on Tuesday declined Daiichi Sankyo's request for an appeal of a decision by the U.S. Court of Appeals for the Federal Circuit that reversed Daiichi's initial win in a patent infringement case against Apotex Corp.

  • February 19, 2008

    Chocolate Price-Fixing Suit Filed In Canada

    Four of the world's top candymakers have been hit with a proposed class action in Canada for allegedly fixing the prices of their chocolate products.

  • February 19, 2008

    Ernst & Young Settles Cendant Case For $298M

    Auditing firm Ernst & Young LLP has settled a lawsuit brought by fraud-riddled travel and real estate giant Cendant Corp. for almost $300 million. The accounting firm allegedly failed to detect huge anomalies in company audits, according to a securities filing by a former Cendant subsidiary.

  • February 15, 2008

    Facing March Trial, Ex-Refco CEO Pleads Guilty

    Former Refco Inc. chief executive Phillip R. Bennett walked out of federal court in Manhattan Friday evening facing the possible equivalent of a life sentence, after pleading guilty to all 20 counts leveled against him by federal prosecutors in a January 2007 indictment.

  • February 15, 2008

    State, Federal Regulators To Discuss Smart Grid

    State and federal regulators say they will assemble a collaborative dialogue about the transition to a smart electric grid, FERC announced Thursday.

  • February 14, 2008

    Novartis Hits Teva With Another Lotrel Suit

    Novartis International AG now has two patent suits pending against generics maker Teva Pharmaceuticals USA Inc. over the blockbuster hypertension drug Lotrel, lodging a new complaint after Teva submitted a bid to make its proposed generic in different dosage strengths.

  • February 13, 2008

    Lamisil Poses Serious Health Risks: Report

    Novartis AG's oral fungal infection treatment Lamisil appears to put patients at risk of serious, and even life-threatening, liver, blood and skin problems, an Australian health regulator has reported.

  • February 12, 2008

    JP Morgan Faces Class Action By N.Y. Loan Officers

    Investment bank JP Morgan Chase & Co. has been hit with a second wage-and-hour class action in the space of two weeks, this time by its army of mortgage loan officers in New York.

  • February 12, 2008

    Amgen Probe Widens As Former Reps Take Action

    An investigation into Amgen Inc.'s alleged privacy violations has widened as two former sales representatives take legal action against the company, seeking to recover compensation they say they lost after objecting to the way psoriasis drug Enbrel was marketed.

  • February 12, 2008

    Wyeth Sues Apotex Over Injectable Protonix ANDA

    Wyeth has filed suit against generics maker Apotex Inc. for allegedly infringing its patent for an injectable version of heartburn treatment Protonix.

  • February 12, 2008

    Senate Backs Bush On Eavesdropping Program

    In a major coup for the Bush administration, the U.S. Senate appeared poised on Tuesday to expand the government's surveillance powers and provide immunity to the phone companies that aided President George W. Bush's domestic eavesdropping program.